Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
Clinical trial NCT05255016 · UNKNOWN
Trial details
- NCT number
- NCT05255016
- Sponsor
- Peschke GmbH
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-14
- Primary completion
- 2023-11-24
- Enrollment
- 488
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.